Back to Agenda
Session 8: Regulatory Writing
Session Chair(s)
Nimita Limaye, PHD
Research VP, Life Sciences R&D Strategy and Technology, at IDC
IDC, United States
Session 8: Panel Discussion: The ROI on RBM - Is it really worth the risk?
Have an account?